Neuro-Oncology
Reviews


Volume 24 Number 10
31 May 2022


Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 10, 31 May






Low JT, Ostrom QT, Cioffi G, Neff C, Waite KA, Kruchko C, Barnholtz-Sloan JS.
Primary brain and other central nervous system tumors in the United States (2014-2018): A summary of the CBTRUS statistical report for clinicians.
Neurooncol Pract. 2022 Feb 22, 2022 Jun;9(3):165-182. doi: 10.1093/nop/npac015. PMID: 35601966. Review.



*

Dono A, Nickles J, Rodriguez-Armendariz AG, McFarland BC, Ajami NJ, Ballester LY, Wargo JA, Esquenazi Y.
Glioma and the gut-brain axis: opportunities and future perspectives.
Neurooncol Adv. 2022 Apr 14, 2022 Jan-Dec;4(1):vdac054. doi: 10.1093/noajnl/vdac054. PMID: 35591978. Review.




Haddad AF, Young JS, Morshed RA, Berger MS.
FLAIRectomy: Resecting beyond the Contrast Margin for Glioblastoma.
Brain Sci. 2022 Apr 25;12(5):544. doi: 10.3390/brainsci12050544. PMID: 35624931. Review.




Pająk B.
Looking for the Holy Grail-Drug Candidates for Glioblastoma Multiforme Chemotherapy.
Biomedicines. 2022 Apr 26;10(5):1001. doi: 10.3390/biomedicines10051001. PMID: 35625738. Review.




Narita Y.
[Glioblastoma That Does Not Improve with Standard Treatment: Poor Prognostic Factors and Future Perspectives].
Brain Nerve. 2022 May 1;74(5):668-676. Japanese. doi: 10.11477/mf.1416202095. PMID: 35589662. Review;




Antonucci L, Canciani G, Mastronuzzi A, Carai A, Del Baldo G, Del Bufalo F.
CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
Front Immunol. 2022 May 4;13:867154. doi: 10.3389/fimmu.2022.867154. PMID: 35603195. Review.




Samples DC, Mulcahy Levy JM, Hankinson TC.
Neurosurgery for Optic Pathway Glioma: Optimizing Multidisciplinary Management.
Front Surg. 2022 May 4;9:884250. doi: 10.3389/fsurg.2022.884250. PMID: 35599811. Review.




Malbari F, Gill J, Daigle A, Rodriguez LL, Raghubar KP, Davis KC, Scheurer M, Ma MM, Kralik SF, Meoded A, Okcu MF, Chintagumpala MM, Aldave G, Weiner HL, Kahalley LS.
Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities.
Pediatr Neurol. 2022 May 5;132:4-10. doi: 10.1016/j.pediatrneurol.2022.04.014. PMID: 35598587. Review;




Afonso M, Brito MA.
Therapeutic Options in Neuro-Oncology.
Int J Mol Sci. 2022 May 11;23(10):5351. doi: 10.3390/ijms23105351. PMID: 35628161. Review.




Baro V, Cerretti G, Todoverto M, Della Puppa A, Chioffi F, Volpin F, Causin F, Busato F, Fiduccia P, Landi A, d'Avella D, Zagonel V, Denaro L, Lombardi G.
Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review.
Curr Oncol. 2022 May 11;29(5):3472-3488. doi: 10.3390/curroncol29050280. PMID: 35621670. Review.




van de Weijer T, Broen MPG, Moonen RPM, Hoeben A, Anten M, Hovinga K, Compter I, van der Pol JAJ, Mitea C, Lodewick TM, Jacquerie A, Mottaghy FM, Wildberger JE, Postma AA.
The Use of 18F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds-A Narrative Review.
Diagnostics (Basel). 2022 May 11;12(5):1202. doi: 10.3390/diagnostics12051202. PMID: 35626357. Review.




Grochans S, Cybulska AM, Simińska D, Korbecki J, Kojder K, Chlubek D, Baranowska-Bosiacka I.
Epidemiology of Glioblastoma Multiforme-Literature Review.
Cancers (Basel). 2022 May 13;14(10):2412. doi: 10.3390/cancers14102412. PMID: 35626018. Review.




Vilar JB, Christmann M, Tomicic MT.
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
Cancers (Basel). 2022 May 13;14(10):2416. doi: 10.3390/cancers14102416. PMID: 35626024. Review.




Kannan S, Murugan AK, Balasubramanian S, Munirajan AK, Alzahrani AS.
Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options.
Biochem Pharmacol. 2022 May 14;201:115090. doi: 10.1016/j.bcp.2022.115090. PMID: 35577014. Review;



*

Ghareghani M, Zibara K, Rieter RJ, Rivest S.
Reduced Melatonin Levels May Facilitate Glioblastoma Initiation in the Subventricular Zone.
Expert Rev Mol Med. 2022 May 16:1-8. doi: 10.1017/erm.2022.15. PMID: 35570582. Review;




Guerrini F, Roca E, Spena G.
Supramarginal Resection for Glioblastoma: It Is Time to Set Boundaries! A Critical Review on a Hot Topic.
Brain Sci. 2022 May 16;12(5):652. doi: 10.3390/brainsci12050652. PMID: 35625037. Review.




Smith HL, Wadhwani N, Horbinski C.
Major Features of the 2021 WHO Classification of CNS Tumors.
Neurotherapeutics. 2022 May 16. doi: 10.1007/s13311-022-01249-0. PMID: 35578106. Review;




Manan AA, Yahya N, Idris Z, Manan HA.
The Utilization of Diffusion Tensor Imaging as an Image-Guided Tool in Brain Tumor Resection Surgery: A Systematic Review.
Cancers (Basel). 2022 May 17;14(10):2466. doi: 10.3390/cancers14102466. PMID: 35626069. Review.




Rasheed S, Rehman K, Shahid M, Suhail S, Akash MSH.
Therapeutic potentials of genistein: New insights and perspectives.
J Food Biochem. 2022 May 17:e14228. doi: 10.1111/jfbc.14228. PMID: 35579327. Review;




Solipuram V, Soltani R, Venkatesulu BP, Annam S, Alavian F, Ghasemi S.
Efficacy of Anti-VEGF Drugs Based Combination Therapies in Recurrent Glioblastoma: Systematic Review and Meta-Analysis.
Curr Rev Clin Exp Pharmacol. 2022 May 17. doi: 10.2174/2772432817666220517163609. PMID: 35585804. Review and Meta-analysis;




Strong MJ, Koduri S, Allison JA, Pesavento CM, Ogunsola S, Ogunsola O, Yee TJ, Khalsa SSS, Saadeh YS, Joseph JR, Kashlan ON, Park P, Oppenlander ME, Szerlip NJ.
Bone metastasis from glioblastoma: a systematic review.
J Neurooncol. 2022 May 17. doi: 10.1007/s11060-022-04025-4. PMID: 35578056. Review;




Vogelbaum MA, Li G, Heimberger AB, Lang FF, Fueyo J, Gomez-Manzano C, Sanai N.
A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology.
Am Soc Clin Oncol Educ Book. 2022 May 17;42:1-8. doi: 10.1200/EDBK_349175. PMID: 35580289. Educational review.




Heinzelmann M, Pan E.
Post-Traumatic Gliomas in Adults: Review of the Case Reports and Studies.
Can J Neurol Sci. 2022 May 18:1-8. doi: 10.1017/cjn.2022.31. PMID: 35581937. Review;




Palmisciano P, Ferini G, Watanabe G, Ogasawara C, Lesha E, Bin-Alamer O, Umana GE, Yu K, Cohen-Gadol AA, El Ahmadieh TY, Haider AS.
Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature.
Cancers (Basel). 2022 May 19;14(10):2507. doi: 10.3390/cancers14102507. PMID: 35626112. Review.



*

Damodharan S, Lara-Velazquez M, Williamsen BC, Helgager J, Dey M.
Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials.
J Pers Med. 2022 May 20;12(5):840. doi: 10.3390/jpm12050840. PMID: 35629262. Review.




Guo X, Jiao H, Zhang T, Zhang Y.
Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis.
Brain Sci. 2022 May 21;12(5):675. doi: 10.3390/brainsci12050675. PMID: 35625061. Meta-analysis.




Bhandari A, Marwah R, Smith J, Nguyen D, Bhatti A, Lim CP, Lasocki A.
Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysis.
J Med Imaging Radiat Oncol. 2022 May 22. doi: 10.1111/1754-9485.13436. PMID: 35599360. Review.




Brown CE, Bucktrout S, Butterfield LH, Futer O, Galanis E, Hormigo A, Lim M, Okada H, Prins R, Marr SS, Tanner K.
The future of cancer immunotherapy for brain tumors: a collaborative workshop.
J Transl Med. 2022 May 23;20(1):236. doi: 10.1186/s12967-022-03438-z. PMID: 35606815. Meeting report.




McAleavey PG, Walls GM, Chalmers AJ.
Radiotherapy-drug combinations in the treatment of glioblastoma: a brief review.
CNS Oncol. 2022 May 23, 2022 Jun 1;11(2):CNS86. doi: 10.2217/cns-2021-0015. PMID: 35603818. Review.




von Knebel Doeberitz N, Paech D, Sturm D, Pusch S, Turcan S, Saunthararajah Y.
Changing paradigms in oncology: toward non-cytotoxic treatments for advanced gliomas.
Int J Cancer. 2022 May 23
. doi: 10.1002/ijc.34131. PMID: 35603902. Review.




Smiley SB, Zarrinmayeh H, Das SK, Pollok KE, Vannier MW, Veronesi MC.
Novel therapeutics and drug-delivery approaches in the modulation of glioblastoma stem cell resistance.
Ther Deliv. 2022 May 26, 2022 Apr;13(4):249-273. doi: 10.4155/tde-2021-0086. PMID: 35615860. Review.




Rizzo A, Savjani R.
The Current Landscape of Clinical Predictions from Brain Tumor Imaging.
Radiol Imaging Cancer. 2022 May 27;4(3):e229011. doi: 10.1148/rycan.229011. PMID: 35621523. Review.



*

Kopecka J, Riganti C.
Overcoming drug resistance in glioblastoma: new options in sight?
Cancer Drug Resist. 2021 Jun 19;4(2):512-516. doi: 10.20517/cdr.2021.03. PMID: 35582029. Editorial overview.









□□□